Sale!

SMN1 Gene Spinal Muscular Atrophy Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SMN1 Gene Spinal Muscular Atrophy Type 2 Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the SMN1 gene, which are indicative of Spinal Muscular Atrophy (SMA) Type 2. SMA Type 2 is a genetic disorder characterized by progressive muscle weakness and atrophy, typically manifesting in early childhood. This condition is caused by the loss or mutation of the survival motor neuron 1 (SMN1) gene, which is crucial for the maintenance and function of motor neurons.

The test, which costs 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, and then analyzing the genetic material for specific mutations in the SMN1 gene. This precise genetic testing allows for an accurate diagnosis of SMA Type 2, enabling healthcare providers to tailor treatment plans and interventions to the specific needs of the patient. Early diagnosis through genetic testing is vital for managing symptoms, improving quality of life, and understanding the prognosis of the condition. DNA Labs UAE offers this test as part of its comprehensive suite of genetic diagnostic services, employing state-of-the-art technology and methodologies to ensure accurate and reliable results.

Description

SMN1 Gene Spinal Muscular Atrophy Type 2 Genetic Test

Test Name: SMN1 Gene Spinal muscular atrophy type 2 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SMN1 Gene Spinal muscular atrophy type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SMN1 Gene Spinal muscular atrophy type 2.

Test Details:

The SMN1 gene is responsible for producing a protein called survival motor neuron (SMN) that is essential for the survival of motor neurons. Spinal muscular atrophy (SMA) is a genetic disorder characterized by the loss of motor neurons in the spinal cord, leading to muscle weakness and atrophy. Spinal muscular atrophy type 2 (SMA2) is a milder form of SMA that typically presents in early childhood. It is characterized by muscle weakness and motor function impairment, but individuals with SMA2 are usually able to sit without support and may eventually be able to stand and walk with assistance.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of SMA2, NGS genetic testing can be used to identify mutations or variations in the SMN1 gene that are associated with the condition. This type of genetic testing can help confirm a diagnosis of SMA2, provide information about the specific genetic variant causing the condition, and determine the carrier status of family members. It can also be used for genetic counseling and family planning purposes.

It is important to note that while NGS genetic testing can be highly accurate, it may not detect all possible mutations or variations in the SMN1 gene. Therefore, a negative test result does not completely rule out the possibility of SMA2. Additionally, other genetic and clinical factors may also contribute to the development and severity of the condition.

Test Name	SMN1 Gene Spinal muscular atrophy type 2 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SMN1 Gene Spinal muscular atrophy type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SMN1 Gene Spinal muscular atrophy type 2
Test Details	The SMN1 gene is responsible for producing a protein called survival motor neuron (SMN) that is essential for the survival of motor neurons. Spinal muscular atrophy (SMA) is a genetic disorder characterized by the loss of motor neurons in the spinal cord, leading to muscle weakness and atrophy. Spinal muscular atrophy type 2 (SMA2) is a milder form of SMA that typically presents in early childhood. It is characterized by muscle weakness and motor function impairment, but individuals with SMA2 are usually able to sit without support and may eventually be able to stand and walk with assistance. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of SMA2, NGS genetic testing can be used to identify mutations or variations in the SMN1 gene that are associated with the condition. This type of genetic testing can help confirm a diagnosis of SMA2, provide information about the specific genetic variant causing the condition, and determine the carrier status of family members. It can also be used for genetic counseling and family planning purposes. It is important to note that while NGS genetic testing can be highly accurate, it may not detect all possible mutations or variations in the SMN1 gene. Therefore, a negative test result does not completely rule out the possibility of SMA2. Additionally, other genetic and clinical factors may also contribute to the development and severity of the condition.